FHIR IG analytics14,182 resources
Start Prev Rows 3200 - 3400 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) |
|---|---|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.4.json | Wound episode value set (foundation metadata concept) | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.6.json | Wound bed appearance value set (foundation metadata concept) | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.60.json | Wound type reference set | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.7.json | Wound bed color value set (foundation metadata concept) | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.74.json | Nonverbal pain indicators reference set | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.76.json | Pain associated signs and symptoms reference set | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.77.json | Pain body location reference set | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.8.json | Wound edge description value set (foundation metadata concept) | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.80.json | Pain quality reference set | active | 2025-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.81.json | Pain speed of onset reference set | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.9.json | Presence absence value set (foundation metadata concept) | active | 2018-07 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1186.1.json | Common drug substances for allergy and intolerance documentation | active | 2024-06 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1186.2.json | Common drug classes for allergy and intolerance documentation | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1186.3.json | Common dietary substances for allergy and intolerance documentation | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1186.4.json | Common environmental substances for allergy and intolerance documentation | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.10.json | NHSNCriterionOfDiagnosisCode(CDCNHSN) | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.11.json | NHSNCriterionOfDiagnosisCode(SNOMEDCT) | active | 2020-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.12.json | NHSNInfectionConditionCode(CDCNHSN) | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.13.json | NHSNInfectionConditionCode(SNOMEDCT) | active | 2020-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.14.json | NHSNInfectionTypeCode(CDCNHSN) | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.15.json | NHSNInfectionTypeCode(SNOMEDCT) | active | 2020-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.16.json | NHSNInfectionFirstReportedSource(CDCNHSN) | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.17.json | NHSNInfectionFirstReportedSource(SNOMEDCT) | active | 2020-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.18.json | NHSNLOS/MENDischargeDisposition(CDCNHSN) | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.19.json | NHSNLOS/MENDischargeDisposition(SNOMEDCT) | active | 2020-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.20.json | NHSNPopulationSummaryReportTypeCode(CDCNHSN) | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.21.json | NHSNPopulationSummaryReportTypeCode(LOINC) | active | 2020-08 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.22.json | NHSNSameDayOutcomeMeasure(CDCNHSN) | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.23.json | NHSNSameDayOutcomeMeasure(SNOMEDCT) | active | 2020-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.24.json | NHSNSignificantPathogenCode(CDCNHSN) | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.25.json | NHSNSignificantPathogenCode(SNOMEDCT) | active | 2020-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.26.json | NHSNSpinalFusionApproachCode(CDCNHSN) | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.27.json | NHSNSpinalFusionApproachCode(SNOMEDCT) | active | 2020-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.28.json | NHSNVascularAccessTypeCode(CDCNHSN) | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.29.json | NHSNVascularAccessTypeCode(SNOMEDCT) | active | 2020-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.30.json | NHSNVascularSpecimenCollectionSite(CDCNHSN) | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.31.json | NHSNVascularSpecimenCollectionSite(SNOMEDCT) | active | 2020-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.38.json | Blood Glucose Laboratory and Point of Care Tests | active | 2023-09 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.6.json | NHSNPathogenCodeARO | active | 2025-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.63.json | Bacterial and Fungal Blood Culture Tests | active | 2022-07 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.7.json | NHSNRoleOfPerformerCode(CDCNHSN) | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.74.json | Enteral Medication Route | active | 2022-07 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.75.json | Intravenous Medication Route | active | 2022-07 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.79.json | Fidaxomicin, Vancomycin, and Metronidazole | active | 2022-07 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.8.json | NHSNRoleOfPerformerCode(SNOMEDCT) | active | 2020-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.85.json | Baloxavir | active | 2023-05 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.86.json | Peramivir | active | 2023-05 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.87.json | Zanamivir | active | 2023-05 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.88.json | Digestive, Intramuscular, Intravenous Route of Administration | active | 2023-10 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.9.json | NHSNRoleOfPerformerCode(HealthCareProviderTaxonomy) | active | 2020-08 | hl7 | nucc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.90.json | NHSN LTC AU Antimicrobial Agents | active | 2024-05 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.91.json | Long Term Care Discharge Disposition | active | 2024-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.94.json | NHSNNeurogenicBladder | active | 2025-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1190.95.json | NHSNSpinalCordInjury | active | 2025-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1196.147.json | SCIP Major Surgical Procedure | active | 2019-06 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1196.3483.json | Financial Insecurity Screening Assessments Questions | active | 2023-07 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1196.3484.json | Food Insecurity Screening Assessments Questions | active | 2023-07 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1196.3485.json | Health Literacy Screening Assessments Questions | active | 2024-12 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1196.3486.json | Homelessness Screening Assessments Questions | active | 2023-08 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1196.3487.json | Housing Instability Screening Assessments Questions | active | 2023-08 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1196.3488.json | Less Than High School Education Screening Assessments Questions | active | 2023-07 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1196.3519.json | Health Insurance Coverage Status Screening Assessments And Questions | active | 2023-07 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1196.3520.json | Inadequate Housing Screening Assessments And Questions | active | 2023-07 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1196.393.json | Hypoglycemics Severe Hypoglycemia | active | 2024-01 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1196.394.json | Hypoglycemics Treatment Medications | active | 2025-02 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1196.4448.json | Lidocaine | active | 2024-05 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1196.491.json | Medium Dose ICS Formoterol Preparations | active | 2021-09 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1196.495.json | ICS LABA LAMA Preparations | active | 2021-09 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1196.788.json | Social Determinants of Health Conditions | active | 2024-12 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.15.json | General Surgery | active | 2020-04 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.17.json | Coagulation Disorder Conditions | active | 2020-04 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.19.json | Anticoagulant Medications | active | 2025-02 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.20.json | Anticoagulant Medications, Oral | active | 2024-03 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.21.json | Anticoagulant Medications, Injection | active | 2024-03 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.28.json | Active Bleeding | active | 2020-11 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.29.json | Fall Risk Increasing Drugs (FRIDs) | active | 2021-07 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.30.json | Fall Risk Factors | active | 2021-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.32.json | Total Hip Arthroplasty Surgery | active | 2021-03 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.33.json | Total Knee Arthroplasty Surgery | active | 2021-03 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.46.json | Opioid Medications | active | 2021-07 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.47.json | Imaging Related to VTE | active | 2023-01 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.48.json | Anticoagulant Medication | active | 2024-03 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.49.json | VTE Diagnoses | active | 2025-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.50.json | Bisphosphonate Therapy | active | 2022-02 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.51.json | VTE Symptoms | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.52.json | Oncology Critical Care Units | active | 2022-03 | hl7 | cdc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.53.json | Provider Types | active | 2022-05 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.56.json | FOBT_Lab | active | 2024-07 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.58.json | Screening Mammogram (CPT) | active | 2024-08 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.59.json | Screening Mammogram (LOINC) | active | 2024-09 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.60.json | Screening Mammogram (SNOMEDCT) | active | 2024-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.61.json | Screening Mammogram (Grouping) | active | 2024-08 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.62.json | Diagnostic Mammography (CPT) | active | 2024-08 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.63.json | Diagnostic Mammography (LOINC) | active | 2024-09 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.64.json | Diagnostic Mammography (SNOMEDCT) | active | 2024-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.65.json | Diagnostic Mammography | active | 2024-08 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.66.json | Breast Cancer Biopsy and Surgical Excision | active | 2024-10 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.67.json | BI_RADS Categories 0, 4, and 5 | active | 2024-10 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.68.json | BI_RADS Categories 1, 2, and 3 | active | 2024-10 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1213.101.json | Local Anesthetics | active | 2023-07 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1213.102.json | Ophthalmic Epinephrines | active | 2023-07 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1213.103.json | Inhaled Epinephrines | active | 2023-07 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1213.104.json | Clopidogrels | active | 2023-10 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1213.105.json | Cytochrome P450 2C19 inhibitors | active | 2023-10 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1213.107.json | Aspirin Ingredient and Risk of GI Bleeding | active | 2023-12 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1213.109.json | Oral Anticoagulant Ingredients and Risk of GI Bleeding | active | 2023-12 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1213.112.json | PPI and Risk of GI Bleeding | active | 2023-12 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1213.113.json | Antiplatelet Ingredients and Risk of GI Bleeding | active | 2023-12 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1213.115.json | Kratom containing compounds | active | 2024-07 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1213.117.json | Clopidogrel Ingredients and Risk of GI Bleeding | active | 2024-09 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1213.121.json | Gastrointestinal bleeding episode and Risk of GI Bleeding 1 | active | 2024-10 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1213.122.json | Gastrointestinal bleeding episode and Risk of GI Bleeding 2 | active | 2024-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1213.123.json | Gastrointestinal bleeding episode and Risk of GI Bleeding | active | 2024-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1213.24.json | Oxycodones | active | 2024-07 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.1.json | Bronchiectasis Disorder SNOMED | active | 2020-04 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.10.json | Interstitial Lung Disease ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.100.json | Occupational Therapy Procedure HCPCS | active | 2022-03 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.101.json | Occupational Therapy Procedure | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.102.json | Speech Language Therapy Procedure HCPCS | active | 2022-03 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.103.json | Speech Language Therapy Procedure | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.104.json | Home Health Procedure | active | 2022-03 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.105.json | Intermittent Skilled Nursing Home Health Procedure | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.106.json | pH, Hematocrit, Partial Pressure Carbon Dioxide, Partial Pressure Oxygen or Bicarbonate Laboratory Test for Breathing Assistance Device Evaluation Excluding Oxygen Saturation | active | 2022-03 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.107.json | Breathing Test Procedure During Sleep | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.108.json | Ambulance Transport Procedure | active | 2022-03 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.109.json | Prefabricated Spinal Orthotic Device | active | 2022-03 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.11.json | Interstitial Lung Disease SNOMEDCT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.110.json | Custom Fitted Spinal Orthotic Device | active | 2022-03 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.111.json | Custom Fabricated Spinal Orthotic Device | active | 2022-03 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.112.json | Orthotic Device Supply | active | 2022-03 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.113.json | Spinal Orthotic Device or Supply | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.115.json | Spine or Neck Disorder SNOMED CT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.116.json | Spine or Neck Disorder ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.117.json | Spine or Neck Disorder | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.118.json | Total Electric Hospital Bed Supply | active | 2022-03 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.119.json | Hypoventilation Disorder SNOMEDCT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.12.json | Interstitial Lung Disease | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.120.json | Hypoventilation Disorder ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.121.json | Hypoventilation Disorder | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.122.json | Respiratory Assist Device Qualifying Condition | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.123.json | Apnea Hypopnea Index Rate Measurement | active | 2022-03 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.124.json | Forced Expiratory Volume in One Second (FEV1)/Forced Vital Capacity (FVC) Measurement | active | 2022-03 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.125.json | Maximal Inspiratory Pressure Measurement | active | 2022-03 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.126.json | Forced Vital Capacity (FVC) Measurement by Spirometry | active | 2022-03 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.127.json | Oxygen Saturation Measurement At Rest | active | 2022-03 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.128.json | Respiratory Assist Device | active | 2022-03 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.129.json | Respiratory Assist Device Supply | active | 2022-03 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.13.json | Cystic Fibrosis Lung Disease ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.130.json | Home Oxygen Therapy Accessory | active | 2022-03 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.131.json | Forced Vital Capacity (FVC) Measurement Prediction | active | 2022-03 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.132.json | Oxygen Saturation Laboratory Test and Setting for Breathing Assistance Device Evaluation | active | 2022-03 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.133.json | Respiratory Disturbance Index | active | 2022-03 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.135.json | Past Medical History Condition Related to Need for Positive Airway Pressure Device | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.137.json | Fracture of Bone Disorder SNOMED CT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.138.json | Fracture of Bone Disorder ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.139.json | Fracture of Bone Disorder | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.14.json | Cystic Fibrosis Lung Disease SNOMEDCT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.140.json | Severe Obesity Disorder SNOMED CT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.141.json | Severe Obesity Disorder ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.142.json | Severe Obesity Disorder | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.143.json | Transfer from Bed Impairment SNOMED CT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.145.json | Transfer from Bed Impairment | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.146.json | Ability to Safely Sit in Chair or Wheelchair Impairment SNOMED CT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.148.json | Ability to Safely Sit in Chair or Wheelchair Impairment | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.149.json | Fall or Fall Risk from Wheelchair or Stretcher SNOMED CT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.15.json | Cystic Fibrosis Lung Disease | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.152.json | Muscle, Tendon or Joint Contracture Disorder SNOMED CT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.153.json | Muscle, Tendon or Joint Contracture Disorder ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.154.json | Muscle, Tendon or Joint Contracture Disorder | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.155.json | Muscle Weakness or Myasthenia Gravis Disorder SNOMED CT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.156.json | Muscle Weakness or Myasthenia Gravis Disorder ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.158.json | Myocardial Infarction Disorder SNOMED CT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.159.json | Myocardial Infarction Disorder ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.16.json | Neoplasm of Lung or Trachea Disorder SNOMEDCT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.160.json | Myocardial Infarction Disorder | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.161.json | Amputation Disorder SNOMED CT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.162.json | Amputation Disorder ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.164.json | Lower Extremity Deep Vein Thrombosis Disorder SNOMED CT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.165.json | Lower Extremity Deep Vein Thrombosis Disorder ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.167.json | Spinal Cord Injury or Paralysis Disorder SNOMED CT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.168.json | Spinal Cord Injury or Paralysis Disorder ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.169.json | Spinal Cord Injury or Paralysis Disorder | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.17.json | Neoplasm of Lung or Trachea Disorder ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.170.json | Demyelinating Disorder SNOMED CT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.171.json | Demyelinating Disorder ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.172.json | Demyelinating Disorder | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.173.json | Grade 2, 3 or 4 Decubitus Ulcer on Buttock Disorder SNOMED CT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.174.json | Grade 2, 3 or 4 Decubitus Ulcer on Buttock Disorder ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.176.json | Wound Disorder SNOMED CT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.177.json | Wound Disorder ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.178.json | Wound Disorder | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.179.json | Danger to Self or Others Disorder SNOMED CT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.18.json | Neoplasm of Lung or Trachea Disorder | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.180.json | Danger to Self or Others Disorder ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.181.json | Danger to Self or Others Disorder | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.182.json | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer SNOMED CT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.183.json | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer ICD10CM | active | 2022-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.184.json | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.185.json | Pain on Movement or Joint Pain Disorder SNOMED CT | active | 2022-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1219.186.json | Pain in Joint Disorder ICD10CM | active | 2022-03 | hl7 | icd |
FHIR
FHIRsmith